Skip to content
Insider tapeFilings through Fri, Oct 2

Kelly A. Kramer

Director at Gilead Sciences, Inc. (GILD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $713K

Reported trades

Filed Stock Type Shares Price Value Since
Dec 1SEC GILDGilead Sciences, Inc. Sell Plan 2,806 $127.11 $357K +13.8%
Dec 1SEC GILDGilead Sciences, Inc. Sell Plan 2,805 $127.10 $357K +13.8%
  • Sell

    Director Kelly A. Kramer sold $357K of GILD at $127.11 — cuts the stake by 68%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Kelly A. Kramer sold $357K of GILD at $127.10 — cuts the stake by 68%; pre-scheduled 10b5-1 plan sale.